Armo BioSciences: Analysis And Valuation Of Recent Immune-Oncology IPO [Seeking Alpha]
ARMO BIOSCIENCES (ARMO)
US:NASDAQ Investor Relations:
armobio.com
Company Research
Source: Seeking Alpha
Armo BioSciences: Analysis And Valuation Of Recent Immune-Oncology IPOSummaryArmo BioSciences is a Silicon Valley-based immune-oncology company that recently launched its $128M IPO on Nasdaq.The key molecule, AM0010 (pegilodecakin), is a long-acting form of human IL-10.We are initiating coverage on Armo BioSciences common stock with a Buy rating and first price target of $83 (53% upside).
Show less
Read more
Impact Snapshot
Event Time:
ARMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARMO alerts
High impacting ARMO BIOSCIENCES news events
Weekly update
A roundup of the hottest topics